The Rx Daily Dose: Recent Episodes
Ian Parnigoni PharmD.
For healthcare providers especially pharmacists, nurses and physicians, we work to provide current information on drug updates, changes in the marketplace, and hot topics in the pharmacy industry.
Here are the links for everything discussed in Episode 86. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:17) FDA approves Tzield for Type 1 Diabetes
- (5:45) Rezvoglar approved as interchangeable biosimilar
- (6:32) New EUA for Kineret for COVID19
CDC website for COVID information - get boosted!
FDA monkeypox response website
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
★ Support this podcast on Patreon ★
Here are the links for everything discussed in Episode 85. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:12) Warning about Xylazine being added into illicit drugs
- (3:39) Flu, COVID, RSV - "The Tripledemic"
PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers
CDC website for COVID information - get boosted!
FDA monkeypox response website
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
★ Support this podcast on Patreon ★
Here are the links for everything discussed in Episode 84. Times are also below so feel free to skip around and get to the updates that interest you.
- 1:05) Tecvayli approval for multiple myeloma
- (6:16) Imjudo approval for liver cancer (HCC)
PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers
CDC website for COVID information - get boosted!
FDA monkeypox response website
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
★ Support this podcast on Patreon ★
Here are the links for everything discussed in Episode 83. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:11) FDA amends EUA for bivalent booster vaccines
- (8:23) FDA announces shortage of immediate release amphetamine salts
PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers
CDC website for COVID information - get boosted!
FDA monkeypox response website
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
★ Support this podcast on Patreon ★
Here are the links for everything discussed in Episode 82. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:10) FDA adds new indication for Boostrix vaccine
- (6:44) FDA updated the authorized fact sheet for Evusheld
PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers
CDC website for COVID information - get boosted!
FDA monkeypox response website
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
★ Support this podcast on Patreon ★
Here are the links for everything discussed in Episode 80. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:14) FDA issues warning related to OTC meds & social media challenges
- (4:20) FDA approval of Skysona for CALD
- (6:07) New indication for Retevmo
- (7:12) FDA approves Relyvrio for ALS
PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers
CDC website for COVID information - get boosted!
FDA monkeypox response website
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
★ Support this podcast on Patreon ★
Here are the links for everything discussed in Episode 80. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:12) FDA approves Spevigo for GPP flares
- (3:03) Daxxify approved for treating glabellar lines
PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers
CDC website for COVID information - get boosted!
FDA monkeypox response website
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
★ Support this podcast on Patreon ★
Here are the links for everything discussed in Episode 79. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:12) FDA authorizes updated booster doses for COVID19
- (5:29) FDA approves Xenpozyme for ASMD
PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers
CDC website for COVID information - get boosted!
FDA monkeypox response website
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
★ Support this podcast on Patreon ★
Here are the links for everything discussed in Episode 78. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:10) FDA final rule on OTC hearing aids
- (1:37) Moderna completes EUA for Omicron-targeting Booster
- (3:00) Pfizer and BioNTech submit EUA for omicron booster
- (4:03) FDA updates EUA for Novovax to include adolescents 12 to 17 years of age
- (5:05) New guidance for Paxlovid drug interactions
- (6:01) Single use vial of COMIRNATY approved
- (6:30) Omnipod 5 approved for children ages 2 and older
- (7:48) Approval of Auvelity for Major Depressive Disorder
PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers
CDC website for COVID information - get boosted!
FDA monkeypox response website
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
★ Support this podcast on Patreon ★
Here are the links for everything discussed in Episode 77. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:10) FDA final rule on OTC hearing aids
- (4:35) Zynteglo gene therapy approved for beta thalassemia
CDC website for COVID information - get boosted!
FDA monkeypox response website
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 76. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:32) FDA issues EUA for JYNNEOS vaccine
- (5:05) FDA approves Enhertu for NSCLC w/ HER2 expression
Other FDA approvals:
- (8:13) - Myfembree
- (8:43) - Nubeqa
- (9:08) - Calquence
- (9:36) - Xofluza
CDC website for COVID information - get boosted!
FDA monkeypox response website
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 75. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:13) Expanded EUA for Veklury
- (5:47) Spikevax vaccine approved by Moderna
Other FDA approvals:
- (9:49) - Quviviq
- (11:13) - Enjaymo
- (12:34) - Felqsuvy
- (13:05) - Vabysmo
CDC website for COVID information - get boosted!
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 74. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:12) New EUA issued for Pfizers Paxlovid, and new COVID antiviral treatment
- (7:25) FDA makes several update to Pfizers COVID vaccine EUA
CDC website for COVID information - get boosted!
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 73. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:17) New EUA issued for molnupiravir for treatment of COVID-19
- (6:10) Apretude approved for pre-exposure prophylaxis/PrEP
- (9:33) New treatment approved for Myasthenia Gravis named Vyvgart
- (12:18) Tezspire approved for severe asthma
CDC website for COVID information - get boosted!
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 72. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:17) FDA approves Voxzogo for achondroplasia
- (3:58) Livtencity approved for treatment resistant CMV
- (7:36) New imaging product, Cytalux, approved to help identify ovarian cancer
CDC website for COVID information - get boosted!
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 71. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:18) Interchangeable MAB - Cyltezo approval
- (5:50) Seglentis approved for pain management
- (8:24) FDA authorizes EUA for Pfizer COVID19 vaccine
Updated CDC recommendations for Pfizer COVID vaccine boosters
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 70. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:16) Approval of Opzelura for atopic dermatitis
- (4:01) Qulipta approved for migraine prevention
- (5:54) New treatment for ALGS - Livmarli
Updated CDC recommendations for Pfizer COVID vaccine boosters
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 69. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:18) Approval of Exkivity for NSCLC
- (4:46) Tivdak approved for cervical cancer
- (7:41) New biosimilar for Luncetis approved called Byooviz
- (10:39) Pfizer/COVID vaccine EUA updates on booster shots
Updated CDC recommendations for Pfizer COVID vaccine boosters
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 68. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:18) Approval of Skytrofa a weekly human growth hormone
- (4:22) Invega Hayfera approved for schizophrenia
- (7:50) FDA issues new warning on JAK inhibitors
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 67. Times are also below so feel free to skip around and get to the drugs that interest you. And I apologize for the echo - need to find a better place to record in the new home :)
- (1:18) COVID19 vaccine approved as brand name Comirnaty
- (8:10) Amended EUA for COVID vaccines
- (10:20) Welireg approved for VHL
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 66. Times are also below so feel free to skip around and get to the drugs that interest you. And I apologize for the echo - need to find a better place to record in the new home :)
- (1:18) Approval of first interchangeable insulin called Semglee
- (6:13) Nexviazyme approved for Pompe disease
- (8:23) Approval of Rezurock for chronic graft vs host disease (CGVHD)
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 65. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:12) Approval of Rylaze for ALL and LBL
- (4:12) New EYA issued for Actemra for COVID19
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 64. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:23) New pediatric indication for Ultomiris for PNH
- (5:18) Pradaxa now approved for VTE in pediatric patients
- (9:34) Rx to OTC switch of Astepro
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 63. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:18) New treatment for weight management - Wegovy
- (6:38) Lybalvi approved for schizophrenia and bipolar 1
- (9:43) Controversial treatment for Alzheimers approved - Aduhelm
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 62. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:17) Approval of Myfembree for uterine fibroids
- (5:05) Lumakras approved for NSCLC
- (8:25) Approval of Truseltiq for cholangiocarcinoma
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 61. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:15) - Empaveli approved for PNH
- (4:35) - Approval of Rybrevant for NSCLC
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 60. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:14) - Jemperli approved for advanced endometrial cancer
- (5:52) - Approval of Zynlonta for DLBCL
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 59. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:15) -New contraceptive approved called Nextstellis
- (3:42) - Trodelvy added indications
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 58. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:27) - Qelbree approved for ADHD
- New indications for Tyvaso and Sarclisa
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 57. Times are also below so feel free to skip around and get to the drugs that interest you.
- (0:47) Approval of Abecma for multiple myeloma
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 56. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:12) Approval of Zegalogue for episodes of hypoglycemia
- (3:29) New indication approved for Arcalyst for pericarditis
- (5:20) Myrbetriq approved for neurogenic detrusor overactivity, NDO
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 55. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:08) Approval on Ponvory for multiple sclerosis
- (5:55) Kimyrsa approval for SSSI including MRSA
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 54. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:15) - Azstarys approved for ADHD
- (4:44) - Approval of Fotivda as new RCC treatment option
- (8:12) - Added indication for Yescarta in follicular lymphoma
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 53. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:12) - EUA issued for Jansenn's COVID Vaccine
- (9:18) - Nulibry approved for Molybdenum Cofactor Deficiency Type A
- (11:55) - Approval of Pepaxto for multiple myeloma
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 52. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:18) Ukoniq approved for certain types of NHL
- (5:18) New treatment for LDL cholesterol, Evkeeza approval
- (8:59) Cosela approval the pre-chemo treatment
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 51. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:15) New treatment for heart failure approved, Verquvo
- (4:57) Cabometyx + Opdivo for advanced RCC
- (9:26) Approval of Tepmetko for NSCLC with MET alterations
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 50. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:14) Gemtesa approval for OAB
- (4:01) New indication for Enhertu
- (7:15) New monthly injectable treatment for HIV - Cabenuva and Vocabria
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 49. Times are also below so feel free to skip around and get to the drugs that interest you.
- (1:19) Margenza approval for HER2+ breast cancer
- (4:05) New oral treatment for prostate cancer going by Orgovyx
- (6:53) Moderna COVID-19 vaccine approval
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 48
- Orladeyo approval
- Danyelza approval
- FDA approval Pfizers/BioNTech COVID19 vaccine
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 47, I'm also including times here so feel free to skip ahead to the topics that interest you. Vaccines should be approved next week, so keep an eye open for that podcast next week
- (1:25) Oxlumo approval for hyperoxaluria
- (4:24) Approval of Imcivree for genetic weight management
- (8:29) New EUAs for COVID 19 treatment
- barcitinib and remdesivir
- casirivimab and imdevimab
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 46, I'm also including times here so feel free to skip ahead to the topics that interest you. I hope everyone has a safe, happy, and socially distanced holiday!
- (1:08) Approval of Zokinvy for Hutchinson-Gilford progeria syndrome
- (4:37) New EUA authorized for banlamivimab for treatment of COVID19
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 45, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:22) Approval of Veklury to treat COVID19
- (8:38) Inmazeb approved for Ebola virus
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 44, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:20) Combination of Opdivo & Yervoy approved for mesothelioma
- (4:53) Nucala approved with new indication
- (8:08) New age group approved for Kalydeco
- (10:46) Xeljanz approved for pcJIA
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 43, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:18) Approval of Gavreto for RET-positive NSCLC
- (5:05) Qdolo approved for pain management in adults
- (6:44) New dosing guidelines and strengths for Trulicity
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 42, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:31) Enspryng approval for NMOSD treatment
- (5:32) Approval of Onureg for AML
- (8:06) Novel treatment for acne called Winlevi
- (8:59) Approval of Sogroya for GHD
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 41, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:18) Monjuvi approved for DLBCL
- (3:07) Approval of Lampit to treat Chagas disease
- (4:52) Evrysdi approved for spinal muscular atrophy
- (8:13) FDA approved Blenrep for multiple myeloma
- (10:09) Approval of Viltepso for Duchenne Muscular Dystrophy
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 40, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:27) Approval of Brextri for COPD maintenance
- (4:45) Xywav approved for cataplexy
- (7:42) New treatment for head lice - Xeglyze
- (10:19) Tecartus approval for MCL
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 39, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:15) - Approval of Rukobia for HIV treatment experienced patients
- (4:30) - Inqovi approved for treatment of MDS
- (7:10) - Approval of Upneeq for acquired blepharoptosis
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 38, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:26) - Approval of Crysvita for TIO
- (4:58) - Fintepla for Dravet syndrome
- (8:19) - New combination for HER-2 going by Phesgo
- (10:56) - Dojolvi approval
CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 37, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:07) Approval of Uplizna for NMOSD
- (4:57) Zepzelca approval for mSCLC
- (7:18) New age indication for Tivicay
- (11:23) Ilaris approved for Still's Disease
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 36, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:03) Zilxi approved for rosacea
- (3:17) AstraZeneca wins new approval for Brilinta
- (5:44) Oriahnn approved for uterine fibroids
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 35, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:19) Added indication for Pomalyst for Kaposi sarcoma
- (4:50) FDA approves Kynmobi for Parkinson's
- (8:57) Opdivo & Yervoy approval for mNSCLC w/ PD-L1
- CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 34, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:15) Retevmo approval
- (4:13) FDA approves Qinlock for GIST
- (6:43) New indication approval for Rubraca
- (8:40) Lynparza gets added indication
- (10:31) NY Time coronavirus updates
- (8:40) CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 33, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:06) New indication for Farxiga
- (4:06) FDA approval of Tabrecta for NSCLC
- (8:40) CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 32, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:30) Approval of Ongentys for Parkinson's disease
- (3:45) MenQuadi vaccine approval
- (5:40) Zejula indication expansion in ovarian cancer
- (7:35) Jublia added age range approval
- (9:30) New Dosing approved for Keytruda
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 31, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:05) Approval of Pemazyre for cholangiocarcinoma
- (5:00) New indication approval for Imbruvica
- (7:25) Trodelvy approved for triple negative breast cancer
- (11:25) CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 30, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:00) FDA approval of Jelmyto
- (5:45) Tukysa approval through Project Orbis collaboration
- (10:55) CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 29, I'm also including times here so feel free to skip ahead to the topics that interest you.
- (1:15) FDA approval Koselugo
- (6:20) Reblozyl gets an added indication
- (8:35) Braftovi plus Erbitux for BRAFV600E mCRC
- (11:20) Nationwide recall of ranitidine
- (14:35) CDC updates on COVID-19 & influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 28.
- FDA approval Sevenfact
- New indication for Imfinzi w/ standard chemotherapy for SCLC
- Pediatric indication for Taltz
- Supplemental application approval for Eucrisa in children 3 months and older
- CDC updates on COVID-19
- CDC updates on influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 27.
- FDA approval of Zeposia for RMS
- FDA statement regarding use of ibuprofen with COVID19 infection
- CDC updates on COVID-19
- CDC updates on influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 26.
- Safety Warning from the FDA on SGLT-2's
- Approval of Epclusa in pediatric patients
- FDA guidance on compounding hand sanitizer
- CDC updates on COVID-19
- CDC updates on influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 25.
- Approval of Isturisa for Cushing's Disease
- Added indication for Ofev in ILD
- New combination Opdivo & Vervoy for HCC
- CDC updates on COVID-19
- CDC updates on influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 24.
- Approval of Sarclisa for Multiple Myeloma
- Durysta approval for OAG and OHT
- New boxed warning for montelukast products
- CDC updates on COVID-19
- CDC updates on influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 23.
- FDA approved Nexletol & Nexlizet
- Approval of Anjeso
- New CGRPs - Vyepti & Nurtec ODT
- Added indication for Nerlynx
- Approval of Barhemsys for PONV
- CDC updates on COVID-19
- CDC updates on influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 22.
- FDA approves 3 new OTCs as part of Rx-to-OTC switch
- Approval new contraceptive - Twirla
- Procysbi granules approved
- CDC updates on COVID-19
- CDC updates on influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 21.
- FDA approval of Pemfexy
- Pizensy approved for chronic idiopathic constipation in adults
- Eisai withdraws Belviq from US market at FDA ask
- CDC updates on COVID-19
- CDC updates on influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 20.
- Palforzia approval for peanut allergy
- Approval of Monoferric for iron deficiency anemia
- Audenz approved for H5N1 flu pandemic
- CDC updates on nCoV - coronavirus
- CDC updated influenza reporting
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 19.
- Dificid gets the FDA nod for pediatric usage
- New combination therapy product for type 2 diabetes - Trijardy
- Update on the novel coronavirus (nCOV)
- "How Chaos at Pharmacy Chains is putting Patients at Risk" - NY Times article
- CVS gives a "this fire is fine" response
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 18.
- FDA approves a label expansion for Ozempic
- Approval of Valtoco for seizure rescue
- Tepezza approval for thyroid eye disease
- FDA approves Tavzerik for epithelioid sarcoma
- Overview of the FDA watchlist
- Overview of whats current with the Coronavirus out of China
Here is a link to the full FDA watchlist
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 17.
- FDA approved Ayvakit
- FDA statement in the risk of cancer while on Belviq
- Mycamine gets added age approval
- FDAs can on e-cigarettes
- California wants to sell generic drugs
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 16.
- Added indication for Fiasp in pediatrics
- Keytruda expanded to include BCG-unresponsive NMIBC with CIS
- FDA warns generic manufacturers to follow the law
- HR5534 is introduced into legislation
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 15.
- Approval of Ervebo for EVD
- Added indication for Lynparza
- Approval of Enhertu for HER2 positive breast cancer
- Ubrelvy approved to treat migraines in adults
- Approval of Dayvigo for insomnia
- Caplyta approved to treat schizophrenia in adults
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 14.
- Xtandi added indication
- Xeljanz XR added indication
- Approval of Padcev for urothelial cancer
- Approval of Vyondys 53 for Duchenne Muscular dystrophy
- Vascepa approval to reduce the risk of cardiovascular events.
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 13.
- Mylan And Biocon launch Ogivri in the US market
- FDA approved the first generics for Gilenya
- Approval of Avsola biosimilar for Remicade
- New indication approval for Tecentriq
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 12.
- Approval of Givlaari for AHP
- Approval of Calquence for CLL & SLL
- The 5th biosimlar approved for Humira - Abrilada
- Approval of Exservan for ALS
- New treatment for Sickle Cell Disease - Oxbryta
- Updated CDC guidelines for PCV13
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 11.
- Approval of Reblozyl for beta thalassemia
- Approval of Brukinsa for mantle cell lymphoma
- Approval of Fetroja for complicated UTI
- Approval of Adakveo for sickle cell disease
- Approval of Xcopri for partial onset seizures
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 10.
- Approval of Talicia to treat H. pylori infection
- Approval of Ziextenzo, a biosimilar for Neulasta
- Approval of Fluzone HD quadrivalent vaccine for 2020/2021 season
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 9.
- Baxdela gets an added indication for CABP
- Approval of IUD Liletta
- Vumerity approved for MS
- Recalled alprazolam
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 8.
- New Drug approval for Cystic Fibrosis - Trikafta
- Approval of Amzeeq
- Additional indication for Farxiga
- Stelara wins a new indication from the FDA
- USP delays new revisions
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 5.
- Approval of Reyvow for migraine headaches
- Secuado approved for schizophrenia
- Added indications for Xarelto
- Xofluza get a new indication - Just in time for flu season
- Updated guidelines for Community-acquired pneumonia (CAP)
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 5.
- Descovy now indicated for use in PrEP
- New dosage form for Fasenra
- First new retinoid in over 20 years - Aklief
- New biosimlar approval for Forteo - PF708
- Approval of Beovu for wet-AMD
- Approval of Scenesse for EPP
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 5.
- Updates to Mavyret
- Additional indication for Darzalex
- Added indication for Invokana
- New orphan drug indication for Rituxan
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 4
- Approval of Rybelsus for treatment of type 2 diabetes
- Expanded indications for Pifeltro & Delstrigo
- Approval of Jynneos vaccine for monkeypox/smallpox
- Update on NDMA found in ranitidine products
- Flu Part 4
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
Connect with Kathy Bender PharmD. on social media:
Instagram Linkedin
Here are the links for everything discussed in Episode 3
- Added indication for Nucala for children 6 years and older
- Approval of Ibsrela for IBS-C treatment
- Added indication for Erleada for mCRPC
- Approval of Keytruda & Lenvima in combination
- Update on NDMA found in ranitidine products
- Flu Part 2
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD on social media:
Twitter Instagram Linkedin
Here are the links for everything discussed in Episode 2
- An updated dosage form and indication for Harvoni/Sovaldi
- FDA approves an added indication for Ofev in patients with SSc-ILD
- The FDA approves Gvoke HypoPen
- A novel vaccine for RSV gets breakthrough designation from the FDA
- GSK acquires Sitari Pharmaceuticals
- CDC flu season for 2019/2020 information
Connect with us:
Twitter Instagram YouTube
therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD on social media:
Twitter: https://twitter.com/IanMParnigoni
Instagram: https://instagram.com/ianp_pharmd
Linkedin: https://www.linkedin.com/in/ianparnigoni/
Here are the links for everything discussed on Episode 1
FDA approves Nourianz
Lilly recieves approval of added indication for Taltz
An update on the national immunoglobulin shortage
The battle for marketshare with PCSK9s
New treatment guidelines for Clostridium difficile infection
Connect with us:
Twitter: https://twitter.com/rx_dose
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter: https://twitter.com/IanMParnigoni
Instagram: https://www.instagram.com/ianp_pharmd/